Mattsson Karin, Nilsson Inger
Lakartidningen. 2002 Dec 12;99(50):5095-7.
The article gives a clinically oriented overview of the efficacy and safety of Ginkgo biloba, St. John's wort, ginseng, Echinacea, saw palmetto and kava based on American experiences. Clinical data support the efficacy for some of these drugs. None of them is free of adverse effects. Generally speaking, trials of herbal medicinal products have been too few, too small and too short. The lack of long-term studies is especially unfortunate since many of the drugs are used for a long time. The difference between American and Swedish legislation on herbal medicine products is described.
本文基于美国的经验，对银杏、圣约翰草、人参、紫锥菊、锯叶棕和卡瓦的疗效与安全性进行了以临床为导向的概述。临床数据支持其中一些药物的疗效。它们无一没有不良反应。一般来说，草药产品的试验数量太少、规模太小且时间太短。由于许多药物使用时间较长，缺乏长期研究尤其令人遗憾。文中还描述了美国和瑞典关于草药产品的立法差异。
